Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells

References

1. Aihara S., Chunming R., Young-Xin Y., Le T., Watanbe K., Komiya T., Sumiyoshi H., Hashimoto H., Nomoto A. 1991; Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5:95–109
   [Google Scholar]
2. Batholomeusz A. I., Wright P. J. 1993; Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Archives of Virology 128:111–121
   [Google Scholar]
3. Bhamarapravati N., Yoksan S., Chayaniyayothin T., Angsubphakorn S., Bunyaratvez A. 1987; Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): clinical, immunological and biological responses in adult volunteers. Bulletin of the World Health Organization 65:189–195
   [Google Scholar]
4. Blok J., McWilliam S. M., Butler H. C., Gibbs A. J., Weiller G., Herring B. L., Hemsley A. C., Aaskov J. G., Yoksan S., Bhamarapravati N. 1992; Comparison of a dengue 2 virus and its candidate vaccine derivative: sequence relationships with the flaviviruses and other viruses. Virology 187:573–590
   [Google Scholar]
5. Brinton A. B. 1986; Replication of flaviviruses. In The Togaviridae and Flaviviridae pp. 327–374 Schlesinger S., Schlesinger M. J. Edited by New York: Plenum;
   [Google Scholar]
6. Cecilia D., Gould E. A. 1991; Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology 181:70–77
   [Google Scholar]
7. Chambers T. J., Hahn C. S., Galler R., Rice C. S. 1990; Flavivirus genome organization, expression, and replication. Annual Review of Microbiology 44:649–688
   [Google Scholar]
8. Chen W., Kawano H., Men R., Clark D., Lai C. J. 1995; Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. Journal of Virology 69:5186–5190
   [Google Scholar]
9. Chomczynski P., Sacchi N. 1987; Single step method of RNA isolation by acid guanidine thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162:156–159
   [Google Scholar]
10. Eckels K. H., Scott R. M., Bancroft W. H., Brown J., Dubois D. R., Summers P. L., Russell P. K., Halstead S. B. 1984; Selection of attenuated dengue-4 viruses by serial passage in primary kidney cells. American Journal of Tropical Medicine and Hygiene 33:684–689
    [Google Scholar]
11. Edelman R., Tacket C. O., Wasserman S. S., Vaughn D. W., Eckels K. H., Dubois D. D., Summers P. L., Hoke C. H. 1994; A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. Journal of Infectious Diseases 170:1448–1455
    [Google Scholar]
12. Gorbalenya A. E., Koonin E. V., Donchenko A. P., Blinov V. M. 1989; Two related superfamilies of putative helicases involved in replication, recombination, repair, and expression of DNA and RNA genomes. Nucleic Acids Research 17:4713–4730
    [Google Scholar]
13. Halstead S. B. 1980; Dengue hemorrhagic fever - a public health problem and a field for research. Bulletin of the World Health Organization 58:1–21
    [Google Scholar]
14. Hahn C. S., Dalrymple J. M., Strauss J. H., Rice C. M. 1987; Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proceedings of the National Academy of Sciences, USA 84:2019–2023
    [Google Scholar]
15. Holzmann H., Heinz F. X., Mandl C. W., Guirakhoo F., Kunz C. 1990; A single amino acid substitution in envelope protein E of tick- borne encephalitis virus leads to attenuation in the mouse model. Journal of Virology 64:5156–5159
    [Google Scholar]
16. Jennings A. D., Gibson C. A., Miller B. R., Mathews J. H., Mitchell C. J., Roehrig J. T., Wood D. J., Taffs F., Sil B. K., Whitby S. N., Whitby J. E., Monath T. P., Minor P. D., Sanders P. G., Barrett A. D. T. 1994; Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. Journal of Infectious Diseases 169:512–518
    [Google Scholar]
17. Jiang W. R., Lowe A., Higgs S., Reid H., Gould E. A. 1993; Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. Journal of General Virology 74:931–935
    [Google Scholar]
18. Kapoor M., Zhang L., Murthi M. P., Padmanabhan R. 1995; Synthesis and characterization of an infectious dengue virus type-2 RNA genome (New Guinea C strain). Gene 162:175–180
    [Google Scholar]
19. Kawano H., Rostaphshov V., Rosen L., Lai C. J. 1993; Genetic determinants of dengue type 4 virus neurovirulence for mice. Journal of Virology 67:6567–6575
    [Google Scholar]
20. Koonin E. V. 1993; Computer-assisted identification of a putative methyltransferase domain in NS5 protein of flaviviruses and gamma 2 protein of reovirus. Journal of General Virology 74:733–740
    [Google Scholar]
21. Lai C. J., Zhao B., Hiroyuki H., Bray M. 1991; Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proceedings of the National Academy of Sciences, USA 88:5139–5143
    [Google Scholar]
22. Lobigs M., Usha R., Nestorowich A., Marshall I. D., Weir R. C., Dalgarno L. 1990; Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology 176:587–595
    [Google Scholar]
23. McKee K. T. Jr Bancroft W. H., Eckels K. H., Redfirld R. R., Summers P. L., Russell P. K. 1987; Lack of attenuation of a candidate dengue-1 vaccine (45AZ5) in human volunteers. American Journal of Tropical Medicine and Hygiene 36:435–442
    [Google Scholar]
24. Mandl C. W., Heinz F. X., Puchhammer-Stockl E., Kunz C. 1991; Sequencing the termini of capped viral RNA by 5′-3′ ligation and PCR. Biotechniques 10:485–486
    [Google Scholar]
25. Maniatis T., Fritsch E. F., Sambrook J. 1982 Molecular Cloning: A Laboratory Manual Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
26. Mason P. W., Mcada P. C., Mason T. L., Fournier M. J. 1987; Sequence of the dengue-1 virus genome in the region encoding the three structural protein and the major non-structural protein NS1. Virology 16:262–267
    [Google Scholar]
27. Monath T. P. 1994; Dengue: the risk of developed and developing countries. Proceedings of the National Academy of Sciences, USA 91:2395–2400
    [Google Scholar]
28. Puri B., Henchal J. Burans, Porter K. R., Nelson W., Watts D. M., Hayes C. G. 1994; A rapid method for detection and identification of flaviviruses by polymerase chain reaction and nucleic acid hybridization. Archives of Virology 134:29–37
    [Google Scholar]
29. Repik P. M., Dalrymple J. M., Brandt W. E., McCown J. M., Russell P. K. 1983; RNA fingerprinting as a method for distinguishing dengue- 1 virus strains. American Journal of Tropical Medicine and Hygiene 32:577–589
    [Google Scholar]
30. Rey F. A., Heinz F. X., Mandl C., Kunz C., Harrison S. C. 1995; The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375:291–298
    [Google Scholar]
31. Shaffer A. L., Wojnar W., Nelson W. 1990; Amplification, detection, and automated sequencing of gibbon interleukin-2 mRNA by Thermus aquaticus DNA polymerase reverse transcription and polymerase chain reaction. Analytical Biochemistry 190:292–296
    [Google Scholar]
32. Sumiyoshi H., Tignor G. H., Shope R. E. 1995; Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. Journal of Infectious Diseases 171:1144–1151
    [Google Scholar]
33. Wengler G., Wengler G. 1991; The carboxyl-terminal part of the NS3 protein of West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase. Virology 147:264–274
    [Google Scholar]